TI
ONCE

Trexquant Investment’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Trexquant Investment’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-19,709
Closed -$771K – 1459
2018
Q4 		$771K Buy
19,709
+3,565
+22% +$155K 0.05% 501
2018
Q3 		$881K Buy
+16,144
New +$1.1M 0.07% 389
2016
Q3 		– Sell
-10,893
Closed -$557K – 1119
2016
Q2 		$557K Buy
+10,893
New +$465K 0.07% 438

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Trexquant Investment's ONCE Position: Q1 2019 in Review

Trexquant Investment sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2019, closing a stake of 19,709 shares — an estimated $771K sold.

Trexquant Investment first reported a position in ONCE in Q2 2016 and held it in 3 quarters. The position peaked at $881K in Q3 2018. 199 funds tracked by Wall St. Rank hold ONCE as of Q1 2019.

  • Trexquant Investment reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Trexquant Investment sold 19,709 Spark Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $771K.
  • Trexquant Investment first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2016 and held it in 3 quarters.
  • Trexquant Investment's Spark Therapeutics, Inc. Common Stock position peaked at $881K in Q3 2018.
  • 199 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Trexquant Investment's 13F filing for Q1 2019, filed 13 May 2019.